Evoke Pharma Market Cap 2012-2024 | EVOK

Evoke Pharma market cap history and chart from 2012 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Evoke Pharma market cap as of January 30, 2025 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.007B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $21.004B 7.69
Dr Reddy's Laboratories (RDY) India $11.286B 21.53
BridgeBio Pharma (BBIO) United States $6.891B 0.00
Bausch Health Cos (BHC) Canada $2.701B 1.99
Supernus Pharmaceuticals (SUPN) United States $2.154B 29.32
Amphastar Pharmaceuticals (AMPH) United States $1.751B 10.53
Personalis (PSNL) United States $0.354B 0.00
Taysha Gene Therapies (TSHA) United States $0.307B 21.43
Assembly Biosciences (ASMB) United States $0.088B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Teligent (TLGT) United States $0.000B 0.00